Debt Financing (Details) - USD ($) |
12 Months Ended | ||
---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Aug. 02, 2024 |
|
Debt Financing [Line Items] | |||
Warrant exercisable term | 5 years | ||
Warrants exercisable into common stock (in Shares) | 50,000 | ||
Exercise price of warrants issued (in Dollars per share) | $ 0.66 | ||
Loans borrowed | $ 500,000 | ||
Cash proceeds | 5,000,000 | ||
Issuance costs | 202,656 | ||
Legal fees | 74,532 | ||
Non-cash warrants issued in connection with debt facility | 53,124 | ||
Transaction fee amount | 75,000 | ||
Deferred costs | $ 101,329 | ||
Debt Facility Financing [Member] | |||
Debt Financing [Line Items] | |||
Aggregate principal amount | $ 3,000,000 | ||
Outstanding principal amount | 10.00% | ||
Warrant exercisable term | 5 years | ||
Warrants exercisable into common stock (in Shares) | 100,000 |
X | ||||||||||
- Definition The represent warrant issued with the debt financing as an issuance cost. No definition available.
|
X | ||||||||||
- Definition Exercise price of warrants issued. No definition available.
|
X | ||||||||||
- Definition Amount of non-cash issuance costs attributed to the debt facility. No definition available.
|
X | ||||||||||
- Definition Transaction Fee Amount. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of annual principal payment for debt instrument. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, after the effects of master netting arrangements, of securities borrowed from entities in exchange for collateral. Includes assets not subject to a master netting arrangement and not elected to be offset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|